Half-lives of albumin and cholinesterase in critically ill patients

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 8, 2008, Pages 1140-1142

  Gamsjäger, Thomas ^a   Brenner, Lydia ^a   Sitzwohl, Christian ^a   Weinstabl, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Albumin; Cholinesterase; Critical care; Halflife

Indexed keywords

ALBUMIN; CHOLINESTERASE;

ALBUMIN BLOOD LEVEL; APACHE; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HALF LIFE TIME; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEASUREMENT; PLASMA; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ALBUMINS; BIOLOGICAL MARKERS; CHOLINESTERASES; CRITICAL ILLNESS; HALF-LIFE; HUMANS; INTENSIVE CARE UNITS; REGRESSION ANALYSIS; TIME FACTORS;

EID: 50249162101     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.220     Document Type: Article

References (18)

1. McCluskey A, Thomas AN, Bowles BJ, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 1996;51:724-7.
2. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.
3. Jokanovic M, Maksimovic M. Abnormal cholinesterase activity: understanding and interpretation. Eur J Clin Chem Clin Biochem 1997;35:11-6.
4. Kamolz LP, Andel H, Greher M, Ploner M, Meissl G, Frey M. Serum cholinesterase activity reflects morbidity in burned patients. Burns 2002;28:147-50.
5. al-Kassab AS, Vijayakumar E. Profile of serum cholinesterase in systemic sepsis syndrome (septic shock) in intensive care unit patients. Eur J Clin Chem Clin Biochem 1995;33:11-4.
6. Ostergaard D, Viby-Mogensen J, Hanel HK, Skovgaard LT. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand 1988;32:266-9.
7. Giovannini I, Chiarla C, Giuliante F, Vellone M, Ardito F, Nuzzo G. The relationship between albumin, other plasma proteins and variables, and age in the acute phase response after liver resection in man. Amino Acids 2006;31:463-9.
8. Hill PG. The measurement of albumin in serum and plasma. Ann Clin Biochem 1985;22:565-78.
9. den Blaauwen DH, Poppe WA, Tritschler W. Cholinesterase (EC 3.1.1.8) with butyrylthiocholine-iodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy. J Clin Chem Clin Biochem 1983;21:381-6.
10. Spiess A, Mikalunas V, Carlson S, Zimmer M, Craig RM. Albumin kinetics in hypoalbuminemic patients receiving total parenteral nutrition. J Parenter Enteral Nutr 1996;20:424-8.
11. Yap FH, Joynt GM, Buckley TA, Wong EL. Association of serum albumin concentration and mortality risk in critically ill patients. Anaesth Intensive Care 2002;30:202-7.
12. Dahn MS, Jacobs LA, Smith S, Lange MP, Mitchell RA, Kirkpatrick JR. The significance of hypoalbuminemia following injury and infection. Am Surg 1985;51:340-3.
13. Barle H, Hammarqvist F, Westman B, Klaude M, Rooyackers O, Garlick PJ, et al. Synthesis rates of total liver protein and albumin are both increased in patients with an acute inflammatory response. Clin Sci (Lond) 2006;110:93-9.
14. Essen P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ, et al. Tissue protein synthesis rates in critically ill patients. Crit Care Med 1998;26:92-100.
15. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985;1:781-4.
16. Holland PC, Hancock SW, Hodge D, Thompson D, Shires S, Evans S. Degradation of albumin in meningococcal sepsis. Lancet 2001;357:2102-4.
17. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000;85:599-610.
18. Benet LZ, Zia-Amirhosseini P. Basic principles of pharmacokinetics. Toxicol Pathol 1995;23:115-23.